Australia markets closed

Radiopharm Theranostics Limited (RAD.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0370-0.0010 (-2.63%)
At close: 04:10PM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) 17.03M
Enterprise value 15.14M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.70
Enterprise value/revenue -992.50
Enterprise value/EBITDA 0.42

Trading information

Stock price history

Beta (5Y monthly) 0.82
52-week change 3-64.39%
S&P500 52-week change 324.16%
52-week high 30.1464
52-week low 30.0270
50-day moving average 30.0351
200-day moving average 30.0624

Share statistics

Avg vol (3-month) 31.49M
Avg vol (10-day) 33.89M
Shares outstanding 5460.37M
Implied shares outstanding 61.09B
Float 875.53M
% held by insiders 130.31%
% held by institutions 17.12%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-469.02%

Management effectiveness

Return on assets (ttm)-30.84%
Return on equity (ttm)-107.05%

Income statement

Revenue (ttm)6.01M
Revenue per share (ttm)0.02
Quarterly revenue growth (yoy)-4.60%
Gross profit (ttm)N/A
EBITDA -33.39M
Net income avi to common (ttm)-46.82M
Diluted EPS (ttm)-0.1400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.89M
Total cash per share (mrq)0
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)0.50
Book value per share (mrq)0.06

Cash flow statement

Operating cash flow (ttm)-22.94M
Levered free cash flow (ttm)-17.75M